US7914814B2
(en)
*
|
1997-09-17 |
2011-03-29 |
Strategic Science & Technologies, Llc |
Topical delivery of arginine of cause beneficial effects
|
US7629384B2
(en)
*
|
1997-09-17 |
2009-12-08 |
Strategic Science & Technologies, Llc |
Topical delivery of L-arginine to cause beneficial effects
|
EP1027045A4
(de)
*
|
1997-10-31 |
2004-12-08 |
Arch Dev Corp |
Methoden und zusammenstellungen zur regelierung des s-alpha-reduktaseaktivität
|
US6946144B1
(en)
*
|
1998-07-08 |
2005-09-20 |
Oryxe |
Transdermal delivery system
|
US7220427B2
(en)
*
|
1998-07-08 |
2007-05-22 |
Oryxe |
Mixture for transdermal delivery of low and high molecular weight compounds
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
ITMI991894A1
(it)
*
|
1999-09-09 |
2001-03-09 |
Carlo Ghisalberti |
Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
|
DE10009424A1
(de)
*
|
2000-02-28 |
2001-09-06 |
Henkel Kgaa |
Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung
|
US20060121103A1
(en)
*
|
2000-05-11 |
2006-06-08 |
Kenneth Kirby |
Transdermal delivery system
|
FR2811562B1
(fr)
*
|
2000-07-13 |
2003-03-07 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et un isoflavonoide
|
FR2811566B1
(fr)
*
|
2000-07-13 |
2003-01-17 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et une vitamine
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
ATE355854T1
(de)
|
2000-08-03 |
2007-03-15 |
Antares Pharma Ipl Ag |
Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
FR2812873B1
(fr)
|
2000-08-11 |
2003-08-01 |
Barry Callebaut France |
Procede de production de polyphenols a partir de feves de cacao
|
ES2309030T3
(es)
|
2000-08-16 |
2008-12-16 |
Unilever N.V. |
Mezclas de isoflanonas y flavonas.
|
EP1180331B1
(de)
*
|
2000-08-16 |
2008-07-09 |
Unilever N.V. |
Mischungen von Isoflavonen und Flavonen
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
FR2815858B1
(fr)
*
|
2000-10-26 |
2003-12-12 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et un agent susceptible d'inhiber l'irritation d'origine neurogene
|
AUPR549901A0
(en)
|
2001-06-06 |
2001-07-12 |
Vital Health Sciences Pty Ltd |
Topical formulation containing tocopheryl phosphates
|
CA2426885C
(en)
*
|
2000-11-14 |
2010-06-29 |
Vital Health Sciences Pty Ltd |
Complexes of phosphate derivatives
|
FR2818135B1
(fr)
|
2000-12-15 |
2003-02-14 |
Oreal |
Composition, notamment cosmetique, renfermant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un carotenoide
|
FR2818148B1
(fr)
|
2000-12-15 |
2005-06-24 |
Oreal |
Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
|
US6607735B2
(en)
|
2000-12-21 |
2003-08-19 |
Johnson & Johnson Consumer Companies, Inc. |
Method for reducing the appearance of dark circles under the eyes
|
NL1017333C2
(nl)
*
|
2001-02-12 |
2002-08-13 |
Gent Natural Products Van |
Cosmetisch resp. farmaceutisch preparaat.
|
US6589591B1
(en)
*
|
2001-07-10 |
2003-07-08 |
Baylor College Of Medicine |
Method for treating medical devices using glycerol and an antimicrobial agent
|
CN1547475B
(zh)
*
|
2001-07-27 |
2010-12-15 |
生命健康科学有限公司 |
含电子转移试剂的磷酸酯衍生物的皮肤制剂
|
WO2003015605A2
(en)
*
|
2001-08-20 |
2003-02-27 |
University Of Virginia Patent Foundation |
Use of s-nitrosothiol signaling to treat disordered control of breathing
|
US8795716B2
(en)
|
2001-10-01 |
2014-08-05 |
The Procter & Gamble Company |
Skin care compositions on a thin sanitary napkin
|
EP1460995B1
(de)
*
|
2001-12-13 |
2010-11-10 |
Vital Health Sciences Pty Ltd. |
Transdermaler transport von verbindungen
|
WO2003077860A2
(en)
*
|
2002-03-13 |
2003-09-25 |
Biophysica, Inc. |
BOSWELLIN COMPOSITIONS ENHANCED WITH 3-β-ACETYL-11-KETO-β-BOSWELLIC ACID (“AKBA”), INDUSTRIAL MANUFACTURE AND THEIR USES
|
DE60318938T2
(de)
|
2002-03-20 |
2009-01-22 |
Mannkind Corp., Valencia |
Inhalationsgerät
|
US7235249B2
(en)
|
2002-03-28 |
2007-06-26 |
The Procter & Gamble Company |
Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions
|
DE10228680A1
(de)
*
|
2002-06-27 |
2004-01-22 |
Holden Development Limited, Tortola |
Grundlage für transdermale Formulierungen (PTF)
|
US7099713B2
(en)
|
2002-06-28 |
2006-08-29 |
Battelle Memorial Institute |
Skin conduction and transport systems
|
AU2002950713A0
(en)
*
|
2002-08-09 |
2002-09-12 |
Vital Health Sciences Pty Ltd |
Carrier
|
US20040062794A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Lee Shulman |
17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
|
US9035123B2
(en)
|
2002-10-01 |
2015-05-19 |
The Procter & Gamble Company |
Absorbent article having a lotioned topsheet
|
AU2003296335A1
(en)
*
|
2002-12-06 |
2004-06-30 |
Board Of Regents, The University Of Texas System |
Compositions and methods related to lipid:emodin formulations
|
ATE534384T1
(de)
*
|
2003-01-17 |
2011-12-15 |
Vital Health Sciences Pty Ltd |
Verbindungen mit proliferationshemmenden eigenschaften
|
WO2004068107A2
(en)
*
|
2003-01-21 |
2004-08-12 |
Transform Pharmaceuticals, Inc |
Apparatus and method for transcellular testing
|
EA012599B1
(ru)
|
2003-04-10 |
2009-10-30 |
Ньюроджескс, Инк. |
Способы и композиции для введения агонистов trpv1
|
US7052715B2
(en)
*
|
2003-04-11 |
2006-05-30 |
All Natural Fmg, Inc. |
Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
|
US7033998B2
(en)
*
|
2003-04-11 |
2006-04-25 |
All Natural Fmg, Inc. |
Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
|
AU2003901815A0
(en)
*
|
2003-04-15 |
2003-05-01 |
Vital Health Sciences Pty Ltd |
Phosphate derivatives
|
FR2855753B1
(fr)
*
|
2003-06-03 |
2007-09-14 |
Dermo Cosmologie Lab De |
Composition a base de diosgenine applicable par voie topique
|
US20050058673A1
(en)
|
2003-09-09 |
2005-03-17 |
3M Innovative Properties Company |
Antimicrobial compositions and methods
|
BRPI0414551B8
(pt)
|
2003-10-10 |
2021-05-25 |
Antares Pharma Ipl Ag |
formulação farmacêutica transdérmica ou transmucosa e método de protelação ou inibição da cristalização de um agente ativo
|
US6998109B1
(en)
|
2004-01-07 |
2006-02-14 |
Pearson Research & Development Limited |
Emu-based formulations with lidocaine for wound treatment by inhibiting microbial activity
|
WO2005074946A1
(en)
*
|
2004-02-10 |
2005-08-18 |
Adenobio N.V. |
Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
|
US20050271597A1
(en)
*
|
2004-02-13 |
2005-12-08 |
Keith Alec D |
Prostate hypertrophy treatment composition and method
|
US20080045909A1
(en)
*
|
2004-02-23 |
2008-02-21 |
Strategic Science & Technologies, Llc. |
Topical Delivery of a Nitric Oxide Donor to Improve and Skin Appearance
|
US20060281716A1
(en)
*
|
2004-03-03 |
2006-12-14 |
West Simon M |
Alkaloid formulations
|
WO2005096990A2
(en)
*
|
2004-04-02 |
2005-10-20 |
Baylor College Of Medicine |
Novel modification of medical prostheses
|
US20050226827A1
(en)
*
|
2004-04-09 |
2005-10-13 |
Thienna Ho |
Skin lightening composition
|
WO2005102282A1
(en)
*
|
2004-04-19 |
2005-11-03 |
Strategic Science & Technologies, Llc |
Transdermal delivery of beneficial substances effected by a hostile biophysical environment
|
US20110028548A1
(en)
*
|
2004-04-19 |
2011-02-03 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
US9226909B2
(en)
|
2004-04-19 |
2016-01-05 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US20050272700A1
(en)
*
|
2004-05-10 |
2005-12-08 |
Servet Buyuktimkin |
Topical treatment and prevention of human papilloma virus (HPV) infection
|
ES2385934T3
(es)
|
2004-08-20 |
2012-08-03 |
Mannkind Corporation |
Catálisis de la síntesis de dicetopiperazina.
|
EP2314298B1
(de)
|
2004-08-23 |
2015-05-27 |
MannKind Corporation |
Mikropartikel enthaltend Diketopiperazinsalze zur Arzneimitteldarreichung
|
AU2005291862B2
(en)
*
|
2004-10-08 |
2010-07-08 |
Clinuvel Pharmaceuticals Limited |
Compositions and methods for inducing melanogenesis in a subject
|
US9415034B2
(en)
*
|
2005-01-05 |
2016-08-16 |
National Defense Medical Center |
Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
|
KR20070121666A
(ko)
*
|
2005-02-14 |
2007-12-27 |
노이로제스엑스, 인코포레이티드 |
Trpv1 작용제의 전달용 장치
|
JP2008531602A
(ja)
*
|
2005-03-03 |
2008-08-14 |
バイタル ヘルス サイエンシズ プロプライアタリー リミティド |
抗癌特性を有する化合物
|
US10918618B2
(en)
|
2005-03-10 |
2021-02-16 |
3M Innovative Properties Company |
Methods of reducing microbial contamination
|
TW200724134A
(en)
|
2005-03-10 |
2007-07-01 |
3M Innovative Properties Co |
Antimicrobial compositions and methods
|
WO2006105481A1
(en)
*
|
2005-03-30 |
2006-10-05 |
Neurogesx, Inc. |
Low-concentration capsaicin patch and methods for treating neuropathic pain
|
US7563464B1
(en)
|
2005-04-22 |
2009-07-21 |
Bruce Eric Hudkins |
Treatment of mucosal membranes utilizing phytoestrogen
|
US7252834B2
(en)
*
|
2005-04-25 |
2007-08-07 |
Clemson University Research Foundation (Curf) |
Elastin stabilization of connective tissue
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
NZ565049A
(en)
*
|
2005-06-17 |
2012-02-24 |
Vital Health Sciences Pty Ltd |
A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
|
KR20160022404A
(ko)
*
|
2005-09-14 |
2016-02-29 |
맨카인드 코포레이션 |
활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
|
EP1940346A2
(de)
*
|
2005-09-30 |
2008-07-09 |
The Procter and Gamble Company |
Zusammensetzung zur regulierung des keratingewebes von säugetieren
|
US8911751B2
(en)
*
|
2005-10-11 |
2014-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions for nasal delivery
|
US7920926B2
(en)
*
|
2005-12-09 |
2011-04-05 |
Apsara Medical Corporation |
Method and apparatus for carrying out the controlled heating of tissue in the region of dermis
|
US20070196301A1
(en)
|
2005-12-21 |
2007-08-23 |
L'oreal |
Cosmetic composition with a volumizing effect
|
FR2894811B1
(fr)
†
|
2005-12-21 |
2008-02-22 |
Oreal |
Composition cosmetique a effet volumateur
|
TW200800223A
(en)
*
|
2005-12-21 |
2008-01-01 |
Shire Pharmaceuticals Inc |
Transdermal delivery of meptazinol
|
CA2631653A1
(en)
*
|
2005-12-23 |
2007-06-28 |
Vital Health Sciences Pty Ltd. |
Compounds having cytokine modulating properties
|
WO2007086931A1
(en)
*
|
2006-01-24 |
2007-08-02 |
Majid Fotuhi |
Dosage regimen and medicament for preventing of reducing risk of onset or progression of dementia by administration of specific vitamins and nsaid
|
MX2008010721A
(es)
|
2006-02-22 |
2008-09-01 |
Mannkind Corp |
Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo.
|
CN101426475A
(zh)
|
2006-04-21 |
2009-05-06 |
安塔雷斯制药Ipl股份公司 |
使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
|
WO2008044095A1
(en)
|
2006-10-11 |
2008-04-17 |
Techfields Biochem Co. Ltd |
Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
|
US20090238763A1
(en)
*
|
2006-07-09 |
2009-09-24 |
Chongxi Yu |
High penetration compositions and uses thereof
|
US20090221703A1
(en)
|
2006-07-09 |
2009-09-03 |
Chongxi Yu |
High penetration composition and uses thereof
|
WO2008012602A1
(en)
|
2006-07-25 |
2008-01-31 |
Techfields Biochem Co. Ltd |
Positively charged water-soluble prodrugs of diclofenac with very fast skin penetration rate
|
JP4869347B2
(ja)
*
|
2006-07-14 |
2012-02-08 |
国立大学法人北海道大学 |
過冷却促進剤
|
PT2041068T
(pt)
|
2006-07-18 |
2017-02-17 |
Techfields Biochem Co Ltd |
Pró-fármacos solúveis em água positivamente carregados de ibuprofeno com taxa de penetração de pele muito rápida
|
EP2990402A1
(de)
|
2006-08-08 |
2016-03-02 |
Techfields Biochem Co. Ltd |
Positiv geladene, wasserlösliche prodrugs von aryl- und heteroarylessigsäuren mit sehr schneller hautpenetrationsgeschwindigkeit
|
ES2694685T3
(es)
|
2006-09-03 |
2018-12-26 |
Techfields Biochem Co. Ltd |
Profármacos solubles en agua cargados positivamente de ácidos n-arilantranílicos con muy rápida velocidad de penetración en la piel
|
CN101506143B
(zh)
|
2006-09-03 |
2013-06-05 |
于崇曦 |
具有快速皮肤穿透速度的带正电荷的水溶性的对乙酰氨基酚及其相关化合物的前药
|
US20080075793A1
(en)
*
|
2006-09-21 |
2008-03-27 |
Dunshee Wayne K |
Antiviral compositions and methods of use
|
JP5378219B2
(ja)
*
|
2006-10-02 |
2013-12-25 |
テックフィールズ バイオケム カンパニー リミテッド |
非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
|
US20080097557A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Apsara Medical Corporation |
Method and apparatus for carrying out the controlled heating of tissue in the region of dermis
|
US9603361B2
(en)
*
|
2006-10-23 |
2017-03-28 |
Ecolab Usa Inc. |
Virucidal composition
|
CA2678500A1
(en)
*
|
2007-02-15 |
2008-08-21 |
Derma-Young Ltd. |
Compositions and methods for enhancing transmucosal delivery
|
CN101687792B
(zh)
|
2007-06-04 |
2016-03-02 |
于崇曦 |
具有快速皮肤和生物膜穿透速度的非甾体抗炎药的前药及其医药用途
|
AU2008298592A1
(en)
|
2007-09-14 |
2009-03-19 |
Nitto Denko Corporation |
Drug carriers
|
US20090155337A1
(en)
*
|
2007-11-12 |
2009-06-18 |
Endologix, Inc. |
Method and agent for in-situ stabilization of vascular tissue
|
GB0801119D0
(en)
|
2008-01-22 |
2008-02-27 |
Barry Callebaut Ag |
Composition
|
EP2257274A4
(de)
*
|
2008-02-21 |
2011-07-20 |
Vatrix Medical Inc |
Behandlung von aneurysma mit anwendung eines bindegewebe-stabilisierenden mittels in kombination mit einem abgabevehikel
|
WO2009120933A2
(en)
|
2008-03-28 |
2009-10-01 |
Particle Sciences, Inc. |
Pharmaceutical solutions and method for solubilizing therapeutic agents
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
EP3281663B8
(de)
|
2008-06-13 |
2022-09-21 |
MannKind Corporation |
Atemluftbetriebener trockenpulverinhalator zur verabreichung von medikamenten
|
MX2010014240A
(es)
|
2008-06-20 |
2011-03-25 |
Mankind Corp |
Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion.
|
WO2009158248A2
(en)
*
|
2008-06-25 |
2009-12-30 |
Elc Management Llc |
Method and compositions for improving skin and body appearance
|
US20100016833A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Ogle Matthew F |
Devices for the Treatment of Vascular Aneurysm
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US9101599B2
(en)
|
2008-09-15 |
2015-08-11 |
Laila Nutraceuticals |
Synergistic anti-inflammatory compositions comprising Boswellia serrata extracts
|
US20100119605A1
(en)
*
|
2008-11-12 |
2010-05-13 |
Isenburg Jason C |
Compositions for tissue stabilization
|
RU2630577C2
(ru)
|
2008-12-04 |
2017-09-11 |
Чунси ЮЙ |
Композиции интенсивного проникновения и их применение
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
US8551528B2
(en)
|
2009-06-12 |
2013-10-08 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
US11684624B2
(en)
|
2009-06-24 |
2023-06-27 |
Strategic Science & Technologies, Llc |
Treatment of erectile dysfunction and other indications
|
EP2445493A1
(de)
|
2009-06-24 |
2012-05-02 |
Strategic Science & Technologies, LLC |
Topische zusammensetzung mit naproxen
|
WO2010151240A1
(en)
*
|
2009-06-24 |
2010-12-29 |
Strategic Science & Technologies, Llc |
Topical composition containing ibuprofen
|
US20110218517A1
(en)
*
|
2009-10-09 |
2011-09-08 |
Ogle Matthew F |
In vivo chemical stabilization of vulnerable plaque
|
US8444624B2
(en)
|
2009-10-19 |
2013-05-21 |
Vatrix Medical, Inc. |
Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
|
EP2496295A1
(de)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
Vorrichtung und verfahren zur simulation von einatmungsanstrengungen
|
WO2011072728A1
(en)
|
2009-12-16 |
2011-06-23 |
Ecolab Inc. |
Composition in form of a gel for the virucidal disinfection of mammalian skin
|
US10071030B2
(en)
|
2010-02-05 |
2018-09-11 |
Phosphagenics Limited |
Carrier comprising non-neutralised tocopheryl phosphate
|
CA2786230A1
(en)
*
|
2010-02-15 |
2011-08-18 |
Laila Nutraceuticals |
A novel boswellia low polar gum resin extract and its synergistic compositions
|
US8828377B2
(en)
|
2010-03-15 |
2014-09-09 |
Laila Nutraceuticals |
Boswellia oil, its fractions and compositions for enhancing brain function
|
CA2794734C
(en)
|
2010-03-30 |
2017-12-12 |
Phosphagenics Limited |
Transdermal delivery patch
|
BR112012033060A2
(pt)
|
2010-06-21 |
2018-02-27 |
Mannkind Corp |
métodos de sistema de liberação de fármaco em pó seco
|
WO2012092523A1
(en)
|
2010-12-29 |
2012-07-05 |
Strategic Science & Technologies, Llc |
Systems and methods for treatment of allergies and other indications
|
CN103429247A
(zh)
|
2010-12-29 |
2013-12-04 |
战略科学与技术有限责任公司 |
勃起功能障碍和其它适应症的治疗
|
US8911468B2
(en)
|
2011-01-31 |
2014-12-16 |
Vatrix Medical, Inc. |
Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
|
TR201101374A1
(tr)
|
2011-02-14 |
2012-09-21 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Flurbiprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
|
EP2685992A4
(de)
|
2011-03-15 |
2014-09-10 |
Phosphagenics Ltd |
Aminochinoline als kinasehemmer
|
TR201103183A1
(tr)
|
2011-04-01 |
2012-10-22 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Ketoprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
|
KR101940832B1
(ko)
|
2011-04-01 |
2019-01-21 |
맨카인드 코포레이션 |
의약 카트리지용 블리스터 패키지
|
TR201103770A1
(tr)
|
2011-04-19 |
2012-11-21 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Nimesulid ve metilsülfonilmetanin topikalfarmasötik bileşimleri.
|
WO2012158944A1
(en)
|
2011-05-18 |
2012-11-22 |
Vatrix Medical, Inc. |
Coated balloons for blood vessel stabilization
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
EP2776053A1
(de)
|
2011-10-24 |
2014-09-17 |
MannKind Corporation |
Verfahren und zusammensetzungen zur schmerzbehandlung
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
HRP20211377T1
(hr)
|
2011-11-23 |
2022-01-07 |
Therapeuticsmd, Inc. |
Prirodne kombinirane hormonske supstitucijske formulacije i terapije
|
WO2013089656A1
(en)
|
2011-12-16 |
2013-06-20 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Topical pharmaceutical compositions of thiocolchicoside and methylsulfonylmethane
|
AU2013262320B2
(en)
|
2012-05-16 |
2018-02-22 |
Techfields Pharma Co., Ltd. |
High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US9283241B2
(en)
|
2012-07-10 |
2016-03-15 |
Clemson University |
Treatment to render implants resistant to diabetes
|
SG11201500218VA
(en)
|
2012-07-12 |
2015-03-30 |
Mannkind Corp |
Dry powder drug delivery systems and methods
|
WO2014024193A1
(en)
*
|
2012-08-07 |
2014-02-13 |
Prodel Pharma Ltd. |
Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients
|
EP2911690A1
(de)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalierbare influenza-impfstoffzusammensetzungen und verfahren
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
EP3587404B1
(de)
|
2013-03-15 |
2022-07-13 |
MannKind Corporation |
Mikrokristalline diketopiperazinzusammensetzungen, verfahren zur herstellung und deren verwendung
|
BR122019026637B1
(pt)
|
2013-07-18 |
2023-09-26 |
Mannkind Corporation |
Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
US9855223B2
(en)
|
2013-08-21 |
2018-01-02 |
Concordia University |
Compositions comprising a dendrimer-resveratrol complex and methods for making and using the same
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
CA2947767A1
(en)
|
2014-05-22 |
2015-11-26 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
CA2951284A1
(en)
|
2014-07-29 |
2016-02-04 |
Therapeuticsmd, Inc. |
Transdermal cream
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US11510859B2
(en)
*
|
2015-07-16 |
2022-11-29 |
Marinomed Biotech Ag |
Method for improving aqueous solubility of water-insoluble or slightly water-soluble drugs
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
US20180235870A1
(en)
*
|
2015-08-17 |
2018-08-23 |
Delivra Inc. |
Transdermal formulations for delivery of berberine compounds, and their use in the treatment of berberine-responsive diseases and conditions
|
US11260018B2
(en)
|
2015-09-17 |
2022-03-01 |
Jrx Biotechnology, Inc. |
Approaches for improving skin hydration and moisturization
|
CN114712308A
(zh)
|
2015-12-09 |
2022-07-08 |
磷肌酸有限公司 |
药物制剂
|
US10688069B2
(en)
|
2016-03-31 |
2020-06-23 |
REV Pharmaceuticals LLC |
Sports health performance composition
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
JP2019513709A
(ja)
|
2016-04-01 |
2019-05-30 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
ステロイドホルモン薬学的組成物
|
CN106349206B
(zh)
*
|
2016-08-29 |
2018-09-21 |
珀莱雅化妆品股份有限公司 |
一种从毛喉鞘蕊花中提取福斯高林的制备方法
|
AU2017381395A1
(en)
|
2016-12-21 |
2019-06-20 |
Phosphagenics Limited |
Process
|
US10385297B2
(en)
|
2017-03-16 |
2019-08-20 |
The Procter & Gamble Company |
Methods for making encapsulate-containing product compositions
|
US11103465B2
(en)
|
2017-11-22 |
2021-08-31 |
Ted's Brain Science, Inc. |
Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|